Male breast cancer in combination with a family history of breast/ovarian cancer was indicative of finding a BRCA2 mutation (P=0.002), which is consistent with a recent population-based British study (Basham et al, 2002). This evidence concerns the gene BRCA2 and ovarian cancer.